Reflections on 2022: A Progressive Year for Phage Therapy

Research output: Contribution to journalEditorialResearchpeer-review

Standard

Reflections on 2022 : A Progressive Year for Phage Therapy. / Clokie, Martha; Sicheritz-Pontén, Thomas.

In: PHAGE: Therapy, Applications, and Research, Vol. 3, No. 4, 2022, p. 181-182.

Research output: Contribution to journalEditorialResearchpeer-review

Harvard

Clokie, M & Sicheritz-Pontén, T 2022, 'Reflections on 2022: A Progressive Year for Phage Therapy', PHAGE: Therapy, Applications, and Research, vol. 3, no. 4, pp. 181-182. https://doi.org/10.1089/phage.2022.29038.editorial

APA

Clokie, M., & Sicheritz-Pontén, T. (2022). Reflections on 2022: A Progressive Year for Phage Therapy. PHAGE: Therapy, Applications, and Research, 3(4), 181-182. https://doi.org/10.1089/phage.2022.29038.editorial

Vancouver

Clokie M, Sicheritz-Pontén T. Reflections on 2022: A Progressive Year for Phage Therapy. PHAGE: Therapy, Applications, and Research. 2022;3(4):181-182. https://doi.org/10.1089/phage.2022.29038.editorial

Author

Clokie, Martha ; Sicheritz-Pontén, Thomas. / Reflections on 2022 : A Progressive Year for Phage Therapy. In: PHAGE: Therapy, Applications, and Research. 2022 ; Vol. 3, No. 4. pp. 181-182.

Bibtex

@article{076c5ca5450e475f922e342c27f7a34b,
title = "Reflections on 2022: A Progressive Year for Phage Therapy",
author = "Martha Clokie and Thomas Sicheritz-Pont{\'e}n",
year = "2022",
doi = "10.1089/phage.2022.29038.editorial",
language = "English",
volume = "3",
pages = "181--182",
journal = "PHAGE: Therapy, Applications, and Research",
issn = "2641-6530",
publisher = "Mary AnnLiebert, Inc. Publishers",
number = "4",

}

RIS

TY - JOUR

T1 - Reflections on 2022

T2 - A Progressive Year for Phage Therapy

AU - Clokie, Martha

AU - Sicheritz-Pontén, Thomas

PY - 2022

Y1 - 2022

U2 - 10.1089/phage.2022.29038.editorial

DO - 10.1089/phage.2022.29038.editorial

M3 - Editorial

C2 - 36793883

AN - SCOPUS:85147357006

VL - 3

SP - 181

EP - 182

JO - PHAGE: Therapy, Applications, and Research

JF - PHAGE: Therapy, Applications, and Research

SN - 2641-6530

IS - 4

ER -

ID: 336563010